Research programme: infectious diseases therapeutics - Schering-Plough/Southern Research Institute
Alternative Names: Infectious diseases therapeutics research programme - Schering-Plough/Southern Research InstituteLatest Information Update: 30 Nov 2009
At a glance
- Originator Schering-Plough; Southern Research Institute
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Viral infections
Most Recent Events
- 25 May 2005 Preclinical trials in Bacterial infections in USA (unspecified route)
- 25 May 2005 Preclinical trials in Viral infections in USA (unspecified route)